The most consequential challenge raised by coinfection is perhaps the inappropriate
generation of recombinant viruses through the exchange of genetic material among different …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers cytokine-
mediated inflammation, leading to a myriad of clinical presentations in COVID-19. The SARS …

Abstract Background Coronavirus-2 (SARS-CoV-2) infection causes an acute respiratory
syndrome accompanied by multi-organ damage that implicates a prothrombotic state …

Abstract Background and Aims Patients with severe coronavirus disease 2019 (COVID‐19)
are at significant risk of thrombotic complications. However, their prothrombotic state is …

Despite the growing knowledge of the clinicopathological features of COVID-19, the
correlation between early changes in the laboratory parameters and the clinical outcomes of …

Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with
gastrointestinal and hepatic manifestation in up to one fifth of patients. Severe acute …

The Coronavirus disease 2019 (COVID)-19 pandemic has already affected millions
worldwide, with a current mortality rate of 2.2%. While it is well-established that severe acute …

Abstract Background Novel coronavirus (SARS‐CoV‐2), which causes COVID‐19, has thus
far affected more than 15 million individuals, resulting in more than 600 000 deaths …

Background Platelet activation and thrombotic events characterizes COVID‐19. Objectives
To characterize platelet activation and determine if SARS‐CoV‐2 induces platelet activation …

Abstract Background Coronavirus Disease 2019 (COVID‐19) is responsible for a worldwide
pandemic, with a high rate of morbidity and mortality. The increasing evidence of an …